Accelerating cell line development through automation

How to implement automation in cell line development

Mammalian cell line development is an integral part of the biopharmaceutical industry across a diverse array of applications from vaccines, therapeutic protein production, recombinant therapies, and drug screening.

The market growth for biotherapeutics has increased dramatically in the past few decades, especially for monoclonal antibodies, and these slow, manual development cycles can no longer keep pace with industry demand.

In this ebook we focus on:

• The current limitations in cell line development
• The reasons to invest in automation
• Ways to establish and sustain automation within your lab
• The outlook for cell line development

Author

Lorraine Wenham

Lorraine is Automata’s Content Manager, dedicated to crafting precise, industry-tailored content that speaks directly to the needs of our users in the life sciences. With two decades of B2B marketing experience, Lorraine brings a strong background in health, R&D, sustainability, and more. Her passion for life sciences drives her commitment to delivering content that informs and empowers professionals in the field.

More articles by this author